Search research articles
Contact Us
Filters
Showing results (21-30 of 33) with videos related to
Page
of 4
Sort By:
Pharmacological Research
|
November 14, 2018
Prenatal metformin exposure or organic cation transporter 3 knock-out curbs social interaction preference in male mice
Valentina R Garbarino, Taylor A Santos, Anastassia R Nelson, et al.
The Journal of Prevention of Alzheimer'S Disease
|
January 31, 2022
Senolytic Therapy to Modulate the Progression of Alzheimer's Disease (SToMP-AD): A Pilot Clinical Trial
M M Gonzales, V R Garbarino, E Marques Zilli, et al.
Veterinary Parasitology
|
February 16, 2013
Lung histopathology, radiography, high-resolution computed tomography, and bronchio-alveolar lavage cytology are altered by Toxocara cati infection in cats and is independent of development of adult intestinal parasites
A Ray Dillon, D M Tillson, J Hathcock, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 19, 2025
Lactoferrin levels in cerebrospinal fluid exhibits isoform-specific associations with Alzheimer's disease
Feiyang Zhao, Raquel Puerta, Yaxi Wang, et al.
Veterinary Parasitology
|
October 8, 2014
Effect of pre-cardiac and adult stages of Dirofilaria immitis in pulmonary disease of cats: CBC, bronchial lavage cytology, serology, radiographs, CT images, bronchial reactivity, and histopathology
A Ray Dillon, D M Tillson, A Wooldridge, et al.
Communications Medicine
|
May 20, 2025
Rapamycin treatment for Alzheimer's disease and related dementias: a pilot phase 1 clinical trial
Mitzi M Gonzales, Valentina R Garbarino, Tiffany F Kautz, et al.
Research Square
|
May 10, 2023
Senolytic therapy to modulate the progression of Alzheimer's Disease (SToMP-AD) - Outcomes from the first clinical trial of senolytic therapy for Alzheimer's disease
Mitzi M Gonzales, Valentina R Garbarino, Tiffany Kautz, et al.
Nature Medicine
|
September 7, 2023
Senolytic therapy in mild Alzheimer's disease: a phase 1 feasibility trial
Mitzi M Gonzales, Valentina R Garbarino, Tiffany F Kautz, et al.
Research Square
|
March 18, 2024
Evaluation of Exploratory Fluid Biomarker Results from a Phase 1 Senolytic Trial in Mild Alzheimer's Disease
Valentina R Garbarino, Juan Pablo Palavicini, Justin Melendez, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
April 24, 2025
Evaluation of exploratory fluid biomarkers from a phase 1 senolytic trial in mild Alzheimer's disease
Valentina R Garbarino, Juan Pablo Palavicini, Justin Melendez, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 33) with videos related to
Sort By:
Page
of 4
Pharmacological Research
|
November 14, 2018
Prenatal metformin exposure or organic cation transporter 3 knock-out curbs social interaction preference in male mice
Valentina R Garbarino, Taylor A Santos, Anastassia R Nelson, et al.
The Journal of Prevention of Alzheimer'S Disease
|
January 31, 2022
Senolytic Therapy to Modulate the Progression of Alzheimer's Disease (SToMP-AD): A Pilot Clinical Trial
M M Gonzales, V R Garbarino, E Marques Zilli, et al.
Veterinary Parasitology
|
February 16, 2013
Lung histopathology, radiography, high-resolution computed tomography, and bronchio-alveolar lavage cytology are altered by Toxocara cati infection in cats and is independent of development of adult intestinal parasites
A Ray Dillon, D M Tillson, J Hathcock, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 19, 2025
Lactoferrin levels in cerebrospinal fluid exhibits isoform-specific associations with Alzheimer's disease
Feiyang Zhao, Raquel Puerta, Yaxi Wang, et al.
Veterinary Parasitology
|
October 8, 2014
Effect of pre-cardiac and adult stages of Dirofilaria immitis in pulmonary disease of cats: CBC, bronchial lavage cytology, serology, radiographs, CT images, bronchial reactivity, and histopathology
A Ray Dillon, D M Tillson, A Wooldridge, et al.
Communications Medicine
|
May 20, 2025
Rapamycin treatment for Alzheimer's disease and related dementias: a pilot phase 1 clinical trial
Mitzi M Gonzales, Valentina R Garbarino, Tiffany F Kautz, et al.
Research Square
|
May 10, 2023
Senolytic therapy to modulate the progression of Alzheimer's Disease (SToMP-AD) - Outcomes from the first clinical trial of senolytic therapy for Alzheimer's disease
Mitzi M Gonzales, Valentina R Garbarino, Tiffany Kautz, et al.
Nature Medicine
|
September 7, 2023
Senolytic therapy in mild Alzheimer's disease: a phase 1 feasibility trial
Mitzi M Gonzales, Valentina R Garbarino, Tiffany F Kautz, et al.
Research Square
|
March 18, 2024
Evaluation of Exploratory Fluid Biomarker Results from a Phase 1 Senolytic Trial in Mild Alzheimer's Disease
Valentina R Garbarino, Juan Pablo Palavicini, Justin Melendez, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
April 24, 2025
Evaluation of exploratory fluid biomarkers from a phase 1 senolytic trial in mild Alzheimer's disease
Valentina R Garbarino, Juan Pablo Palavicini, Justin Melendez, et al.
Page
of 4